Large B-CELL Lymphoma

ROBUST trial – Phase III Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Compare the Efficacy and Safety of Lenalidomide (CC-5013) Plus R-CHOP Chemotherapy (R2-CHOP) Versus Placebo Plus R-CHOP Chemotherapy in Subjects with Previously Untreated, Non-Germinal Center Type Diffuse Large B-cell Lymphoma

Disease Types


Available at

BethesdaClintonColumbiaRockvilleSilver SpringWheaton


Cheryl A. Young, RN, BSN
(410) 964-2212 ext 1137